Share on StockTwits

McKesson Corp. (NYSE:MCK) will be releasing its Q414 earnings data on Monday, May 12th. Analysts expect McKesson Corp. to post earnings of $2.40 per share and revenue of $35.89 billion for the quarter.

McKesson Corp. (NYSE:MCK) opened at 166.72 on Friday. McKesson Corp. has a 1-year low of $109.82 and a 1-year high of $188.02. The stock’s 50-day moving average is $171.2 and its 200-day moving average is $167.8. The company has a market cap of $38.367 billion and a price-to-earnings ratio of 33.79.

MCK has been the subject of a number of recent research reports. Analysts at FBR Capital Markets cut their price target on shares of McKesson Corp. from $201.00 to $192.00 in a research note on Wednesday, April 9th. On a related note, analysts at Goldman Sachs upgraded shares of McKesson Corp. from a “buy” rating to a “conviction-buy” rating in a research note on Wednesday, March 12th. They now have a $215.00 price target on the stock, up previously from $208.00. Finally, analysts at Mizuho raised their price target on shares of McKesson Corp. from $194.00 to $199.00 in a research note on Monday, March 3rd. They now have a “buy” rating on the stock. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, nine have assigned a buy rating and three have given a strong buy rating to the company. The company presently has an average rating of “Buy” and a consensus target price of $188.60.

McKesson Corporation delivers pharmaceuticals, medical supplies and healthcare information technologies.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.